Zr89 + PET Companion Trial
NCT05279027
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
6
Enrollment
OTHER
Sponsor class
Conditions
Melanoma (Skin)
Interventions
DRUG:
Zirconium Zr 89 Crefmirlimab Berdoxa
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
[object Object]